| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |